Pharmaceutical research and development (R&D) stands at a pivotal inflection point, characterized by a dynamic shift away from the traditional…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
The landscape of modern medicine has been profoundly shaped by covalent drugs, a class of therapeutics whose impact dates back…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
The digital health company MEDVi, recently spotlighted in an April 2 New York Times profile that depicted CEO Matthew Gallagher…
Read More
Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.
Eli Lilly has ascended to the pinnacle of the pharmaceutical industry, claiming the top spot on the prestigious Pharma 50…
Read More
Rubedo Life Sciences Pivots from Cosmetic Enhancement to Biological Rejuvenation with Senescent Cell Clearance for Age-Related Skin Conditions
Dr. Frederick Beddingfield III, a seasoned pharmaceutical executive known for his instrumental role in scaling Botox into a multi-billion-dollar franchise…
Read More
JAMA Study Links Moderate Caffeine Intake to Lower Dementia Risk, Providing a Potent Nudge for Adenosine Pathway Drug Hunters
A comprehensive prospective cohort study, published online February 9, 2026, in the prestigious journal JAMA, has unveiled compelling evidence suggesting…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
An ambitious new international collaboration, bolstered by a prestigious pan-European EUREKA grant, is set to revolutionize the treatment landscape for…
Read More
Terray’s TerraBind Delivers 26x Faster Inference and Enhanced Accuracy, Challenging Diffusion-Based AI Models in Drug Discovery
In a significant development poised to reshape the landscape of AI-driven drug discovery, Terray Therapeutics, a Los Angeles-based startup, has…
Read More
How Digital Tools and AI Are Accelerating Drug Discovery
The landscape of pharmaceutical innovation has long been characterized by arduous timelines, exorbitant costs, and a high probability of failure,…
Read More
FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts
Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read More
